Paper

Tree Display

AceDB Schema

XML Display

Feedback

Paper Report for: Zhang_2022_Biomed.Pharmacother_155_113704

Reference

Title: The dipeptidyl peptidase-4 inhibitor linagliptin ameliorates LPS-induced acute lung injury by maintenance of pulmonary microvascular barrier via activating the Epac1/AKT pathway
Zhang N, Tang S, Zhang J, Pei B, Pang T, Sun G
Ref: Biomed Pharmacother, 155:113704, 2022 : PubMed

        



Related information

Inhibitor | Linagliptin,


Citations formats

Zhang N, Tang S, Zhang J, Pei B, Pang T, Sun G (2022)
The dipeptidyl peptidase-4 inhibitor linagliptin ameliorates LPS-induced acute lung injury by maintenance of pulmonary microvascular barrier via activating the Epac1/AKT pathway
Biomed Pharmacother 155: 113704

Zhang N, Tang S, Zhang J, Pei B, Pang T, Sun G (2022)
Biomed Pharmacother 155: 113704



Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer